An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
StemPoint Capital Announces Strategic Relationship with Leucadia Asset Management
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
StemPoint Capital, specializing in life sciences investment, has formed a strategic partnership with Leucadia Asset Management, a subsidiary of Jefferies Financial Group (NYSE:JEF). This collaboration includes Leucadia acquiring a minority interest in StemPoint, which aims to leverage investment opportunities in biotechnology and pharmaceuticals. Michelle Ross, StemPoint's Chief Investment Officer, expressed optimism about the partnership's potential to enhance their business strategy and execution in these sectors. Leucadia's leadership emphasized their commitment to supporting StemPoint's growth, citing their extensive industry experience.
Positive
Strategic partnership with Leucadia Asset Management may enhance investment opportunities.
Leucadia's minority investment provides financial backing to StemPoint.
Collaboration aims to leverage growth in biotech and pharmaceutical sectors.
Negative
None.
NEW YORK--(BUSINESS WIRE)--
StemPoint Capital LP (“StemPoint”), a long-biased equity asset management firm dedicated to the global life sciences industry, today announced that it has entered into a strategic relationship with Leucadia Asset Management, a division of Jefferies Financial Group Inc. (NYSE: JEF). In connection with the transaction, Leucadia Asset Management will acquire a minority economic interest in StemPoint.
"I am thrilled to announce the exciting strategic relationship between Leucadia Asset Management and StemPoint. This strategic relationship not only allows us to advance as a business, but also leverage incredible investment opportunities in the biotech and pharmaceutical sectors. At StemPoint, we are committed to identifying and supporting the most promising potential opportunities in these industries and with Leucadia Asset Management by our side, we are confident in our ability to execute on this strategy. I am excited for the future of StemPoint and the possibilities that this strategic relationship brings,” said Michelle Ross, Chief Investment Officer and Managing Partner of StemPoint.
“We have been looking to expand in the healthcare space for many years and are very excited to be doing so with StemPoint. Michelle and her team bring a differentiated view on how to invest in life sciences based on their many years of industry experience at top-notch firms. We look forward to helping them grow and succeed,” said Nick Daraviras and Sol Kumin, Co-Presidents of Leucadia Asset Management.
About StemPoint Capital
StemPoint was founded and officially launched on January 3, 2023, by Michelle Ross, the Chief Investment Officer and Managing Partner. Michelle Ross comes with nearly 20 years of investment management experience at esteemed firms such as Soros Fund Management and PointState Capital. StemPoint seeks to leverage growth aspects of the biotechnology sector and defensive qualities of the pharmaceutical industry to potentially generate absolute returns in varying market cycles.
About Leucadia Asset Management
Leucadia Asset Management offers institutional clients an innovative range of investment strategies through its affiliated asset managers. Leucadia Asset Management is a division of Jefferies Financial Group Inc. (NYSE: JEF).
Leucadia Asset Management / Jefferies Financial Group Jonathan Freedman 212-778-8913
mediacontact@jefferies.com
Source: StemPoint Capital LP
FAQ
What is the new partnership involving Jefferies Financial Group (NYSE:JEF)?
Jefferies Financial Group's division, Leucadia Asset Management, has entered a strategic relationship with StemPoint Capital, acquiring a minority interest.
How does the partnership affect StemPoint Capital's business strategy?
The partnership aims to enhance StemPoint's investment strategies in biotech and pharmaceuticals, leveraging Leucadia's expertise.
